Citation Impact
Citing Papers
Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
2009
Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase
1992
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Endocrine care of transpeople part I. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transmen
2015
Fertility options in transgender people
2015
Interactive Digital Education Aid in Breast Reconstruction
2008
Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure
1996
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
THE INDEPENDENT EFFECTS OF HYPERANDROGENAEMIA, HYPERINSULINAEMIA, AND OBESITY ON LIPID AND LIPOPROTEIN PROFILES IN WOMEN*
1990
Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication
1995
Hidradenitis Suppurativa
2012 Standout
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Management of Acne
2003
Estrogen and progesterone receptor mRNA are expressed in distinct pattern in male primate reproductive organs
1995
Acanthosis Nigricans, Insulin Action, and Hyperandrogenism: Clinical, Histological, and Biochemical Findings*
1991
Ki-67 immunostaining in 322 primary breast cancers: Associations with clinical and pathological variables and prognosis
1997
Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day)
2000
Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene
1994 StandoutNature
Endocrine intervention for transsexuals
2003
Molecular Properties of Corticosteroid Binding Globulin and the Sex-Steroid Binding Proteins*
1990
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study1
1998 Standout
Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
1989
Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
1994
Biochemical and Physiological Aspects of Endogenous Androgens
2009
Immunocytochemical Analysis of Estrogen Receptors in Human Breast Carcinomas
1990
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Comparative Pharmacology of Newer Progestogens
1996
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
1994 Standout
Results of an Open One‐Year Study with Diane‐35 in Women with Polycystic Ovarian Syndrome
1993
Tissue microarrays for high-throughput molecular profiling of tumor specimens
1998 Standout
Polycystic Ovary Syndrome
1995 Standout
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Acne vulgaris
2011 Standout
Effects of conjugated oestrogen and droloxifene on the renin–angiotensin system, blood pressure and renal blood flow in postmenopausal women
2004
Polycystic Ovary Syndrome
2005 Standout
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
1988 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Treatment of hirsutism with the pure antiandrogen flutamide
1990
Suppression of Hyperandrogenism Does not Improve Peripheral or Hepatic Insulin Resistance in the Polycystic Ovary Syndrome*
1990
The Ki-67 protein: From the known and the unknown
2000 Standout
17α-Hydroxylase/17,20-Lyase Deficiency: From Clinical Investigation to Molecular Definition*
1991
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1
1999 Standout
The impact of gender on the progression of chronic renal disease
1995
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Liposomes in cosmeceutics
2012
Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
2009
Spironolactone as a single agent for long‐term therapy of hirsute patients
2000
Some Aspects of the Biological Role of Adenosine 3',5'-monophosphate (Cyclic AMP)
1968 StandoutNobel
Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy
1986
A CONTROLLED TRIAL OF ANTEPARTUM GLUCOCORTICOID TREATMENT FOR PREVENTION OF THE RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS
1972 Standout
Factors Influencing Adenosine 3′,5′-Phosphate Accumulation in Bovine Thyroid Slices
1968 StandoutNobel
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Functional and Structural Relationships in Steroidogenesis in Vitro by Human Corpora Lutea during Development and Regression*
1981 StandoutNobel
The Stimulatory Effect of Luteinizing Hormone on Adenosine 3‘,5‘-Monophosphate Accumulation in Corpus Luteum Slices
1966 StandoutNobel
Genetic and hormonal control of male sexual differentiation
1975 StandoutNobel
The pharmacology and clinical uses of tamoxifen
1984
Familial Incomplete Male Pseudohermaphroditism, Type 2
1974 StandoutNobel
Familial Incomplete Male Pseudohermaphroditism, Type 1
1974 StandoutNobel
Expression of Renin and Angiotensinogen Genes in the Human Placental Tissues.
1987
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Functional and Structural Relationships in Steroidogenesisin Vitroby Human Ovarian Follicles during Maturation and Ovulation*
1978 StandoutNobel
Further studies upon steroid transformations in the human corpus luteum
1967
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Deletion 9p and sex reversal.
1993
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
EXCRETION OF URINARY OESTROGENS IN PREGNANT PATIENTS TREATED WITH CORTISONE AND ITS ANALOGUES
1968
Pseudovaginal perineoscrotal hypospadias
1972
Time Relationships Between Granulosa Cells Growth and Luteinization, and Plasma Luteinizing Hormone Discharge in Human. I. A Morphometric Analysis
1972
Decision aids for people facing health treatment or screening decisions
2017 Standout
The effect of gonadotropins on testicular adenyl cyclase
1969 StandoutNobel
Guidelines on the use of antirheumatic drugs in women during pregnancy and child-bearing age
1990
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Mechanisms of Estrogen Action
2001 Standout
Comparative Effects of Cyproterone Acetate or a Long-Acting Gonadotropin-Releasing Hormone Agonist in Polycystic Ovarian Disease
1986
Sex differences in unipolar depression: Evidence and theory.
1987 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Ovulatory Disorders in Women with Polycystic Ovary Syndrome
1985
The polycystic ovary syndrome presenting as resistant acne successfully treated with cyproterone acetate
1991
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
2000 Standout
CORRELATIONS BETWEEN PROGESTERONE, OESTRADIOL AND ALDOSTERONE LEVELS IN THE PREMENSTRUAL SYNDROME
1981
Brain Corticosteroid Receptor Balance in Health and Disease*
1998 Standout
Interrelations between Progesterone and the Ovary, Pituitary, and Central Nervous System in the Control of Ovulation and the Regulation of Progesterone Secretion
1966
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
2011 Standout
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
The prognostic value of oncogenic antigen 519 (OA‐519) expression and proliferative activity detected by antibody MIB‐I in node‐negative breast cancer
1995
Estradiol With or Without Progesterone and Ambulatory Blood Pressure in Postmenopausal Women
1999
Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.
1995
4 Anti-androgens in gynaecological practice
1988
Steroid hormone formation in the human ovary: VII
1971
11 Treatment of hirsutism and acne with cyproterone acetate
1986
Prolactin levels during short- and long-term cross-sex hormone treatment: an observational study in transgender persons
2016
Hypothalamic Control of Adenohypophysial Secretions
1973 StandoutNobel
Works of J. Hammerstein being referenced
Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6β-hydroxycortisol
1993
Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male
1992
Depression and Anxiety Symptoms in Women at High Risk for Breast Cancer: Pilot Study of a Group Intervention
1999
Steroid Hormone Formation in the Human Ovary: I. Identification of Steroids Formedin Vitrofrom Acetate-1-14C in the Corpus Luteum
1964
Antiandrogens in the treatment of acne and hirsutism
1983
TREATMENT OF HIRSUTISM AND OTHER SIGNS OF VIRILISM WITH A REVERSED SEQUENTIAL ADMINISTRATION OF CYPROTERONE ACETATE AND ETHINYL OESTRADIOL CLINICAL AND ENDOCRINOLOGICAL ASPECTS
1971
17α-HYDROXYLASE DEFICIENCY OF THE GONADS AND ADRENALS IN A MALE PSEUDOHERMAPHRODITE
1973
Grundlagen der hormonalen Kontrazeption
1972
[Hormonal research on endocrine causes of male pseudohermaphroditism].
1958
Steroid Hormone Formation in the Human Ovary: II. Action of Gonadotropinsin Vitroin the Corpus Luteum
1964
Growth fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies.
1987
Effects of Ethinylestradiol on the Renin- Angiotensin-Aldosterone-System and on Plasma Transcortin in Women and Men*†
1976
MODE OF ACTION OF CLOMIPHENE
1969
Ovarian and adrenal vein steroids in healthy women with ovulatory cycles—selective catheterization findings
1984
VERMINDERTE OESTROGEN-AUSSCHEIDUNG IN DER SCHWANGERSCHAFT NACH SUBTOTALER ADRENALEKTOMIE
1965
Effects of various replacement oestrogens on hepatic transcortin synthesis in climacteric women
1983
MODE OF ACTION OF CLOMIPHENE. I. INHIBITORY EFFECT OF CLOMIPHENE CITRATE ON THE FORMATION OF PROGESTERONE FROM ACETATE-1-14C BY HUMAN CORPUS LUTEUM SLICES IN VITRO
1969
Polyzystische Ovarien: eigenständiges Krankheitsbild oder unspezifisches Symptom?*
1985
RELATIONSHIPS BETWEEN WEIGHT CHANGES AND RENIN, ALDOSTERONE, ESTROGENS AND PROGESTERONE IN CYCLICAL EDEMA
1973
Behandlung des Hirsutismus mit Cyproteronacetat*
1969
XY Gonadal Dysgenesis
1981
The concentration of 6-keto-PGF1α and TXB2 in plasma samples from patients with benign and malignant tumours of the breast
1985
Steroid hormone formation in the human ovary: III. Action of gonadotropins on testosterone synthesis by normal ovarian stromal tissue
1964
The treatment of hissutism with cyproterone acetate.
1969
Ovarian and adrenal vein steroids in patients with nonneoplastic hyperandrogenism: selective catheterization findings
1984
Medium dose cyproterone acetate (CPA): Effects on hormone secretion and on spermatogenesis in men
1980
Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
1975